The Latest in Keratoconus Treatment - Summary - MDSpire
Advertisement
The Latest in Keratoconus Treatment
While corneal transplantation allows for excellent vision, it also exposes the keratoconus patient to significant risks. Recent innovations in keratoconus management have developed to greatly improve quality of life for these patients.
To summarize recent advancements in the treatment of keratoconus, focusing on management strategies that limit disease progression and optimize vision, particularly through early intervention.
Key Findings:
Corneal crosslinking can slow or halt keratoconus progression, significantly reducing the need for transplants.
Scleral lenses provide significant visual rehabilitation for many patients, although some may still struggle with fit.
New surgical techniques (CAIRS and CTAK) offer less invasive options for reshaping the cornea, which may improve patient quality of life.
Interpretation:
Early diagnosis and treatment of keratoconus are crucial to prevent progression and improve patient outcomes, highlighting a shift towards proactive management rather than reactive transplantation.
Limitations:
Epi-off crosslinking can cause discomfort and delayed healing, impacting patient adherence to treatment.
Not all patients achieve vision improvement post-crosslinking, necessitating alternative solutions.
Some patients may still be unable to wear contact lenses despite treatment, limiting their options.
Conclusion:
Keratoconus management has evolved significantly, allowing patients to avoid transplantation through early intervention and innovative treatments, underscoring the need for continued research.
